A new study reports the discovery of a genetic variant that is associated with a patient's likelihood of responding to interferon-beta. The study also presents evidence that the affected gene, SLC9A9, may have a broader role in regulating the development and activity of certain immune cells that play important roles in inflammatory diseases like multiple sclerosis.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1bZ6QzE
No comments:
Post a Comment